Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction

Takashi Tanaka; T Tanaka; Naohiko Umesaki; N Umesaki; Sachio Ogita; S Ogita

doi:10.3109/09513590009167708

Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction

Takashi Tanaka, T Tanaka, Naohiko Umesaki, N Umesaki, Sachio Ogita, S Ogita

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2000 · vol. 14(5) , pp. 388–391 · doi:10.3109/09513590009167708 · PMID:11109979 · W2022079061

article OA: closed CC0 ⤵ 1 in-corpus citation

View on OpenAlex View on PubMed View at publisher

Abstract

We report the rare case of a patient with adenomyosis who showed thyroid dysfunction of unknown etiology during treatment for endometriosis. She responded to nafarelin acetate and danazol when she was euthyroid but not to buserelin acetate when she was hyperthyroid. This suggests that the response to anti-endometriotic medicine in our patient was altered by impaired thyroid function and that this could occur in other such patients.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Buserelin Danazol Endometriosis Hyperthyroidism Nafarelin Adult Buserelin CA-125 Antigen CA-125 Antigen Cinnamomum zeylanicum Danazol Endometriosis Endometriosis Endometriosis Estrogen Antagonists Estrogen Antagonists Female Hormones Hormones Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex
A New Therapy for Pelvic Endometriosis and Uterine Adenomyosis: Local Effect of Vaginal and Intrauterine Danazol Application via openalex
A preliminary immunopharmacological study of an antiendometriotic herbal medicine, Keishi-bukuryo-gan. via openalex
CA 125 Antigen Is an Effective Diagnostic for External Endometriosis via openalex
Changes in thyroid function tests during danazol therapy via openalex
Danazol Suspension Injected into the Uterine Cervix of Patients with Adenomyosis and Myoma via openalex
Plasma and peritoneal fluid levels of CA 125 in women with endometriosis via openalex
TRH test before, during, and after long-term danazol treatment in patients with endometriosis via openalex
W42372792 via openalex

Cited by (1)

Case report Transient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report 2008

Source provenance

europepmc: last seen: 2026-06-12T06:13:51.797165+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:13:30.513821+00:00

License: CC0 · commercial use OK

[1] A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex

[2] A New Therapy for Pelvic Endometriosis and Uterine Adenomyosis: Local Effect of Vaginal and Intrauterine Danazol Application via openalex

[3] A preliminary immunopharmacological study of an antiendometriotic herbal medicine, Keishi-bukuryo-gan. via openalex

[4] CA 125 Antigen Is an Effective Diagnostic for External Endometriosis via openalex

[5] Changes in thyroid function tests during danazol therapy via openalex

[6] Danazol Suspension Injected into the Uterine Cervix of Patients with Adenomyosis and Myoma via openalex

[7] Plasma and peritoneal fluid levels of CA 125 in women with endometriosis via openalex

[8] TRH test before, during, and after long-term danazol treatment in patients with endometriosis via openalex

[9] W42372792 via openalex